China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020

Similar documents
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

EU5 Bariatric Surgery Procedures Outlook to 2020

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Mexico Ostomy Drainage Bags Market Outlook to 2020

Asia-Pacific Electrophysiology Market Outlook to 2020

SAMPLE. South Korea Orthopedic Procedures Outlook to Reference Code: GDMEMC0008PDB. Publication Date: March 2014

SAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB

SAMPLE. South and Central America Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central

SAMPLE. North America Propylene Industry Outlook to 2017 GDCH0615RDB/JAN 2013

France Interventional Cardiology Market Outlook to 2020

Oncology Therapeutics Market in India to 2018

Ostomy Drainage Bags Market to Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential

SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous

Russia Cardiac Assist Devices Market Outlook to 2021

SAMPLE. Cerebral Palsy Global Clinical Trials Review, H1, 2014

Globaldata. Publisher Sample

Hip & Knee Orthopedic Surgical Implants Market: Country wise Outlook

SAMPLE. Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012

More information at

Nephrology and Urology Devices Market to Usage of. Incontinence devices by the Elderly Population to Drive Market

REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

Country Coverage. Company Coverage

o Dental Implants Market By Material, Type, Structure Global Forecast To 2022 Report ID: MRDH Publishing Date: July, 2017

REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

Arthroscopy Devices Market to Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Future Growth

Parenteral Nutrition Market to 2018

Dry Eye Syndrome - Current and Future Players. GDHC1016FPR / Published May 2013

Global Dental Implant Market Research Report 2018

Table of Contents: JULY TH EDITION

REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHCER046 PUBLICAT ION DATE OCTOBER 2013 DIABETIC FOOT ULCERS - EPIDEMIOLOGY FORECAST TO 2022

Global Cosmetic Dentistry Market Research Report 2018

REFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013

REFERENCE CODE GDHC1062CFR PUBLICATION DATE JUNE 2013 CHRONIC HEART FAILURE - JAPAN DRUG FORECAST AND MARKET ANALYSIS TO 2022

Orencia (Rheumatoid Arthritis)

LUPUZOR (SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS) - FORECAST AND MARKET ANALYSIS TO 2022

Rituxan (Rheumatoid Arthritis)

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)

Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - GLOBAL ANALYSIS AND MARKET FORECASTS

REFERENCE CODE GDME1086CFR PUBLICAT ION DATE FEBRUARY 2014 BIOPSY DEVICES APAC ANALYSIS AND MARKET FORECASTS

REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013

REFERENCE CODE GDME0190M AR PUBLICATION DATE JUNE 2014 SPINAL FUSION GLOBAL ANALYSIS AND MARKET FORECASTS

REFERENCE CODE GDHC013POA PUBLICAT ION DATE DECEM BER 2013

Kaletra (HIV) Forecast and Market Analysis to GDHC1051DFR/ Published January 2013

Bariatric Surgery Devices - North America Analysis and Market Forecasts

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research

REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022

PegIntron (Hepatitis C Virus) Forecast and Market Analysis to GDHC1143DFR / Published May 2013

Actemra (Rheumatoid Arthritis)

REFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1114CFR PUBLICATION DATE M AY 2013

Reference Code: GDME1163IDB. Czech Republic Dental Devices Market Outlook to CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental

North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021

Global Coverage. Regional Coverage. Company Coverage. Country Coverage. Global Coverage Regional Coverage Country Coverage

Chronic Myeloid Leukemia (CML)

Global Coverage. Regional Coverage. Country Coverage Company Coverage

Global Zinc Chemicals Market Study ( )

Dry Eye Syndrome. US Drug Forecast and Market Analysis to GDHC1115CFR / Published May 2013

REFERENCE CODE GDHC1170DFR PUBLICATION DATE M AY 2013

REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

Sofosbuvir and Sofosbuvir/Ledipasvir (Hepatitis C Virus) Forecast and Market Analysis to GDHC1150DFR / Published May 2013

Keppra (Epilepsy) Forecast and Market Analysis to Reference Code: GDHC1061DFR Publication Date: February 2013

REFERENCE CODE GDHC519DFR PUBLICAT ION DATE DECEMBER 2014 LOTRONEX (IRRITABLE BOWEL SYNDROME) FORECAST AND MARKET ANALYSIS TO 2023

Cyclokat (Dry Eye Syndrome)

Tobacco Insights May

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

Mammography Equipment Market to 2019

GLOBAL NEUROSTIMULATION MARKET

REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS

REFERENCE CODE GDHCER PUBLICAT ION DATE M AY 2015 GLAUCOMA EPIDEMIOLOGY FORECAST TO 2023

Tissue Engineering Market Analysis, Size, Share, Growth, Industry Trends and Forecast to Hexa Research

REFERENCE CODE GDHCER043 PUBLICAT ION DATE NOVEMBER 2013 PARKINSON S DISEASE - EPIDEMIOLOGY FORECAST TO 2022

Lamictal (Epilepsy) Forecast and Market Analysis to Reference Code: GDHC1062DFR Publication Date: February 2013

REFERENCE CODE GDHC109PIDR PUBLICAT ION DATE MAY 2015 FIBROMYALGIA GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC1042FPR PUBLICAT ION DATE DECEMBER 2014 IRRITABLE BOWEL SYNDROME CURRENT AND FUTURE PLAYERS

Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022

# $ pages In Stock. Report Description

Diquas (Dry Eye Syndrome)

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic

REFERENCE CODE GDHC398DFR PUBLICAT ION DATE M ARCH 2014 SAFINAMIDE (PARKINSON S DISEASE) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC183CFR PUBLICAT ION DATE NOVEM BER 2013 ATOPIC DERMATITIS US DRUG FORECAST AND MARKET ANALYSIS TO 2022

BRIC DIABETES DRUGS MARKET

REFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

Transcription:

China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1

1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures... 4 2 Introduction... 5 2.1 What Is This Report About?... 5 2.2 Cranio Maxillofacial Fixation (CMF) Market Segmentation... 5 2.3 Definitions of Markets Covered in the Report... 6 3 Cranio Maxillofacial Fixation (CMF) Market, China... 7 3.1 Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), 2005-2012... 7 3.2 Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), 2012-2020... 9 3.2.1 Cranio Maxillofacial Fixators Market, China, Revenue ($m), by Segment, 2005-2012... 11 3.2.2 Distraction Systems Market, China, Revenue ($m), by Segment, 2005-2012... 13 3.2.3 Cranio Maxillofacial Fixators Market, China, Revenue ($m), by Segment, 2012-2020... 15 3.2.4 Distraction Systems Market, China, Revenue ($m), by Segment, 2012-2020... 17 3.3 Cranio Maxillofacial Fixation (CMF) Market, China, Volume (Units), 2005-2012... 19 3.4 Cranio Maxillofacial Fixation (CMF) Market, China, Volume (Units), 2012-2020... 21 3.4.1 Cranio Maxillofacial Fixators Market, China, Volume (Units), by Segment, 2005-2012... 23 3.4.2 Distraction Systems Market, China, Volume (Units), by Segment, 2005-2012... 25 3.4.3 Cranio Maxillofacial Fixators Market, China, Volume (Units), by Segment, 2012-2020... 27 3.4.4 Distraction Systems Market, China, Volume (Units), by Segment, 2012-2020... 29 3.5 Cranio Maxillofacial Fixation (CMF) Market, China, Average Price ($), 2005-2020... 31 3.6 Cranio Maxillofacial Fixation (CMF) Market, China, Distribution Share by Revenue ($m), 2011-2012... 32 3.7 Cranio Maxillofacial Fixation (CMF) Market, China, Company Share by Revenue ($m), 2011-2012... 33 4 Overview of Key Companies in China Cranio Maxillofacial Fixation (CMF) Market... 35 4.1 DePuy Companies... 35 4.1.1 Company Overview... 35 4.2 Stryker Corporation... 35 4.2.1 Company Overview... 35 4.3 China Kanghui Holdings... 35 4.3.1 Company Overview... 35 4.4 KLS Martin, L.P.... 36 4.4.1 Company Overview... 36 4.5 Biomet, Inc.... 36 4.5.1 Company Overview... 36 5 Cranio Maxillofacial Fixation (CMF) Market Pipeline Products... 37 6 Financial Deals Landscape... 38 6.1 Partnerships... 38 6.1.1 Biomet Microfixation Enters Into Distribution Agreement With Oxford Performance Materials For OsteoFab Cranial Implants... 38 Page 2

7 Appendix... 40 7.1 Research Methodology... 41 7.1.1 Coverage... 41 7.1.2 Secondary Research... 41 7.1.3 Primary Research... 42 7.1.4 Market Modeling and Forecasting... 43 7.1.5 Company Share Analysis... 46 7.1.6 Distribution Share Analysis... 47 7.2 Expert Panel... 48 7.3 GlobalData Consulting... 48 7.5 Disclaimer... 48 Page 3

1.1 List of Tables Table 1: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012... 8 Table 2: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020... 10 Table 3: Cranio Maxillofacial Fixators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012... 12 Table 4: Distraction Systems Market, China, Revenue ($m), USD Constant, Historic, 2005-2012... 14 Table 5: Cranio Maxillofacial Fixators Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020... 16 Table 6: Distraction Systems Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020... 18 Table 7: Cranio Maxillofacial Fixation (CMF) Market, China, Volume (Units), Historic, 2005-2012... 20 Table 8: Cranio Maxillofacial Fixation (CMF) Market, China, Volume (Units), Forecast, 2012-2020... 22 Table 9: Cranio Maxillofacial Fixators Market, China, Volume (Units), Historic, 2005-2012... 24 Table 10: Distraction Systems Market, China, Volume (Units), Historic, 2005-2012... 26 Table 11: Cranio Maxillofacial Fixators Market, China, Volume (Units), Forecast, 2012-2020... 28 Table 12: Distraction Systems Market, China, Volume (Units), Forecast, 2012-2020... 30 Table 13: Cranio Maxillofacial Fixation (CMF) Market, China, Average Price ($), Historic, 2005-2012... 31 Table 14: Cranio Maxillofacial Fixation (CMF) Market, China, Average Price ($), Forecast, 2012-2020... 31 Table 15: Cranio Maxillofacial Fixation (CMF) Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012.. 32 Table 16: Cranio Maxillofacial Fixation (CMF) Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012... 34 Table 17: Cranio Maxillofacial Fixation (CMF) Market Pipeline Products... 37 Table 18: Biomet Microfixation Enters Into Distribution Agreement With Oxford Performance Materials For OsteoFab Cranial Implants... 38 Table 19: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country... 43 1.2 List of Figures Figure 1: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012... 7 Figure 2: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020... 9 Figure 3: Cranio Maxillofacial Fixators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012... 11 Figure 4: Distraction Systems Market, China, Revenue ($m), USD Constant, Historic, 2005-2012... 13 Figure 5: Cranio Maxillofacial Fixators Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020... 15 Figure 6: Distraction Systems Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020... 17 Figure 7: Cranio Maxillofacial Fixation (CMF) Market, China, Volume (Units), Historic, 2005-2012... 19 Figure 8: Cranio Maxillofacial Fixation (CMF) Market, China, Volume (Units), Forecast, 2012-2020... 21 Figure 9: Cranio Maxillofacial Fixators Market, China, Volume (Units), Historic, 2005-2012... 23 Figure 10: Distraction Systems Market, China, Volume (Units), Historic, 2005-2012... 25 Figure 11: Cranio Maxillofacial Fixators Market, China, Volume (Units), Forecast, 2012-2020... 27 Figure 12: Distraction Systems Market, China, Volume (Units), Forecast, 2012-2020... 29 Figure 13: Cranio Maxillofacial Fixation (CMF) Market, China, Company Share (%), 2012... 33 Figure 14: GlobalData Epidemiology-Based Forecasting Model... 45 Figure 15: GlobalData Capital Equipment-Based Forecasting Model... 46 Figure 16: Primary Interviews by Participant Type (%)... 47 Page 4

2 Introduction Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms of revenues, unit sales, distributors and competitors. 2.1 What Is This Report About? This report provides an overview and the following information related to the country, various segments, distribution share and competitive landscape in the market: 1. Comprehensive data related to the market revenue, unit sale, average price, company share and distribution share. 2. Corporate-level profiles of key companies operating in the Cranio Maxillofacial Fixation (CMF) market, which includes a brief overview of the company. The selection of the companies is based on their operational presence. 3. A list of key products under development by different companies. The selection of this list is based on the territory in which these products are being clinically investigated. 4. Key news and deals related to the Cranio Maxillofacial Fixation (CMF) market. 2.2 Cranio Maxillofacial Fixation (CMF) Market Segmentation Cranio Maxillofacial Fixation (CMF) market is segmented as described below, in this report: 1. Distraction Systems Distraction Systems includes sub-segments such as Internal Distraction Systems and External Distraction Systems 2. Cranio Maxillofacial Fixators Cranio Maxillofacial Fixators includes sub-segments such as Resorbable Fixators and Non-Resorbable Fixators Page 5

2.3 Definitions of Markets Covered in the Report Cranio Maxillofacial Fixation (CMF) Cranio Maxillofacial Fixation (CMF) includes devices used to restore the anatomic configuration of the cranium and facial bones (mandible, maxilla, frontal bone and others). The devices can either be internal or external. These devices are used in all types of cranio maxillofacial skeletal surgeries, including trauma surgery, oncologic surgery, orthognathic and craniofacial surgery. Distraction Systems Distraction Systems are used in the patients with craniofacial deformities to distract two bone segments for bone lengthening and correct complex facial deformities. This category includes external and internal distraction systems. One unit consists of one distraction system. External Distraction Systems External Distraction Systems are devices fixed externally to reform complex craniofacial deformities. One unit consists of one external distraction system. Internal Distraction Systems Internal Distraction Systems are distraction devices used to distract two bone segments for bone lengthening resulting in correction of deformities of the mandible. One unit consists of one internal distraction system. Cranio Maxillofacial Fixators Cranio Maxillofacial Fixators are used for cranial and maxillofacial reconstruction or fixation. These devices are further categorized into resorbable and non-resorbable fixation systems. Non-Resorbable Fixators Non-resorbable fixators are implants made of various metals and alloys (such as titanium, stainless steel and cobalt-chromiummolybdenum). The implants are available as plates, meshes, screws and clamps. One unit consists of one customized kit. Resorbable Fixators Resorbable fixators are implants made of resorbable polymers that provide various clinical advantages eliminating the need for a second operation for their removal. The implants are available as plates, meshes, screws and clamps. One unit consists of one customized kit. Page 6

3 Cranio Maxillofacial Fixation (CMF) Market, China 3.1 Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), 2005-2012 Figure 1: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 Source: GlobalData Page 7

Table 1: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 Category 2005 2006 2007 2008 2009 2010 2011 2012 CAGR 05-12 Total % Growth Source: GlobalData Page 8

3.2 Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), 2012-2020 Figure 2: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 Source: GlobalData Page 9

Table 2: Cranio Maxillofacial Fixation (CMF) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 Category 2012 2013 2014 2015 2016 2017 2018 2019 2020 CAGR 12-20 Total % Growth Source: GlobalData Page 10

3.2.1 Cranio Maxillofacial Fixators Market, China, Revenue ($m), by Segment, 2005-2012 Figure 3: Cranio Maxillofacial Fixators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 Source: GlobalData Page 11

Table 3: Cranio Maxillofacial Fixators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 Segment 2005 2006 2007 2008 2009 2010 2011 2012 CAGR 05-12 Total % Growth Source: GlobalData Page 12

7 Appendix The data and analysis within this report are driven by Medical etrack. Medical etrack gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following: 15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries, from 2005 and forecast to 2020 6,000+ primary expert interviews, conducted annually to ensure data and report quality 1,100+ medical equipment conference reports 1,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities and competitive landscape 600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends and issues, and investment and M&A trends worth over $3m 50,000+ medical equipment company profiles 2,000+ private, emerging and technology start-up company profiles 4,000+ company profiles of medical equipment manufacturers in China and India 2,000+ company profiles of medical equipment manufacturers in Japan 825+ companies revenue splits and market shares 1,100+ quarterly and annual medical equipment company financials 700+ medical equipment company SWOTs 11,700+ pipeline product profiles 14,000+ marketed product profiles 16,900+ clinical trials 17,000+ trial investigators 18,000+ new product patents 3,700+ reports on companies with products in development 21,500+ reports on deals in the medical equipment industry 1,300+ surgical and diagnostic procedures by therapy area 50+ key healthcare indicators by country Page 40

For more information or to receive a free demonstration of the service, please visit: http://www.medicaletrack.com/contactus.aspx?id=requestdemo 7.1 Research Methodology GlobalData s dedicated research and analysis teams consist of experienced professionals with advanced statistical expertise and marketing, market research and consulting backgrounds in the medical devices industry. GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Research Association (http://www.ephmra.org/). All GlobalData databases are continuously updated and revised. 7.1.1 Coverage The objective of updating GlobalData s coverage is to ensure that it represents the most up-to-date vision of the industry possible. Changes to the industry taxonomy are built on the basis of extensive research of company, association and competitor sources. Company coverage is based on three key factors: revenue; product and media attention; and innovation and market potential. The estimated revenue of all major companies, both private and public, are gathered and used to prioritize coverage. GlobalData aims to cover all major news events and deals in the medical devices industry, updated on a daily basis. The coverage is further streamlined and strengthened with additional input from GlobalData s expert panel. 7.1.2 Secondary Research The research process begins with extensive secondary research using internal and external sources to gather all relevant data and information pertaining to a particular market model for a particular country. The secondary research sources that are typically referred to include, but are not limited to: Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings Industry trade journals, scientific journals and other technical literature Association and healthcare organization websites PubMed, Medscape and other relevant services which compile extensive reviews of clinical literature Internal proprietary databases Relevant patent and regulatory databases Page 41

National government documents, statistical databases and market reports Procedure registries News articles, press releases and web-casts specific to the companies operating in the market 7.1.3 Primary Research GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis. A typical research interview fulfills the following functions: Provides first-hand information on market size, market trends, growth trends, competitive landscape and future outlook Helps to validate and strengthen secondary research findings Further develops the analysis team s expertise and market understanding Primary research involves email correspondence, telephone interviews and face-to-face interviews for each market, category, segment and sub-segment across a range of geographies. The participants who typically take part in such a process include, but are not limited to: o o o o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers Distributors, paramedics and representatives from hospital stores, laboratories and pharmacies Outside experts: investment bankers, valuation experts and research analysts that specialize in specific medical equipment markets Key opinion leaders: physicians and surgeons that specialize in the therapeutic areas in which the medical device is used The following table lists the total number of primary research participants by country, in this case for the orthopedic devices market. Market data is validated using input from 1,200 primary research participants. These include demand-side stakeholders such as orthopedic surgeons, and supply-side participants such as marketing managers, sales managers and product managers of companies manufacturing/marketing orthopedic devices. Page 42

Table 19: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country Country Total number of primary research participants US 80 UK 104 Germany 83 France 86 Italy 85 Spain 75 Brazil 80 China 90 India 112 Russia 64 Japan 74 Australia 71 Canada 66 Mexico 64 South Korea 66 Total 1,200 Source: GlobalData 7.1.4 Market Modeling and Forecasting GlobalData uses an epidemiology-based treatment flow model and capital equipment-based model to estimate and forecast market size. Epidemiology-Based Market Model and Forecasting The epidemiology-based forecasting model uses epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow pattern for individual diseases and therapies. The data covers prevalence, incidence, diseased population, diagnosed population, and treatment population. The market forecast begins with the general population, the size of which varies depending on the indication. Prevalence is the percentage of the total population that suffers from a particular disease or condition. Incidence is the number of new cases of a condition, symptom, death or injury that develop during a specific time period, such as one year. The diseased population is the population suffering from a particular disease or condition. The diagnosed population is the population that has been diagnosed with a particular disease or condition, expressed as a percentage of the prevalence population. The treatment population is the percentage of the population that has been diagnosed with a particular disease or condition. Page 43

Device uptake is the percentage of the treatment population using a particular device, determined based on the primary responses and the information available in secondary sources. The epidemiology-based forecasting model for a medical device is used to: Determine the patient segment using a particular device or procedure Determine the frequency of usage of a particular device depending on the patient type, which further helps to determine the absolute unit sales of a device in a year The market for any medical device is directly proportional to the volume of units sold and the price per unit. Market size = volumes of units sold X ASP (Average Selling Price) The volume of units sold is calculated from the number of patients using or that has been implanted with the device. Data on treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, is gathered from interviews with physicians and used to estimate the patient volume for the disease under consideration. The ASP of a device is mostly gathered from primary and secondary sources. ASP is the price at which a device is available in a target country to an end-user. For capital equipment, the end-user is typically considered to be the healthcare setting. For implants and consumables purchased by patients, the end-user is the patient. Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into consideration during ASP analysis, which uses the following sources: Company websites Annual reports/industry reports Press releases Page 44

Epidemiology-Based Forecasting Model Figure 14: GlobalData Epidemiology-Based Forecasting Model Source: GlobalData Capital Equipment-Based Market Model and Forecasting The capital equipment-based forecasting model is based on the installed base, replacements and new sales of a specific type of capital equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. The installed base is calculated from the average number of units per facility. Sales for a particular year are arrived at by calculating the number of replacement units and new units (additional and first-time purchases). Secondary sources and interviews with supply-side participants and key opinion leaders from healthcare facilities are used to arrive at installed base and unit sales for a particular year. The factors typically affecting the forecast growth rates are: Growth in the number of healthcare facilities Healthcare spending and government programs and initiatives Migration from low-end equipment to high-end equipment Growth in the diagnosed population and treatment population Page 45

Capital Equipment-Based Forecasting Model Figure 15: GlobalData Capital Equipment-Based Forecasting Model Source: GlobalData 7.1.5 Company Share Analysis Company shares are calculated by analyzing a company s sales in a particular market. In the case of public companies, annual reports and regulatory filings, investor presentations, earnings call transcripts and broker reports are used to determine a company s revenue in a particular market and in a particular geography. In the case of the private companies, company share data is gathered mostly from primary interviews and secondary sources. Company share analysis is based on primary interviews with: Supply side (manufacturers) o o Procurement side Distributors Page 46

Hospital purchasing groups Demand side (surgeons/specialists) The benefits of this approach are: High number of respondents to validate and from which to derive accurate company shares Broad view from the supply, demand, and procurement side Prevents biased opinions being reproduced Demand-side interviews with key opinion leaders help to understand their preferences for the devices of specific companies, strengthening company share estimates Primary Interviews by Participant Type Figure 16: Primary Interviews by Participant Type (%) 25 50 25 Procurement side Supply side Demand side The final company share data is based on input from the supply side, the procurement side and the demand side, as well as secondary sources. 7.1.6 Distribution Share Analysis Distribution share information is gathered using a combination of secondary and primary research. It is supported by primary interviews because the availability of secondary data is limited in most cases. Page 47

7.2 Expert Panel GlobalData uses a panel of experts to cross-verify its databases and forecasts. GlobalData s expert panel comprises marketing managers, product specialists, international sales managers from medical device companies, academics from research universities, key opinion leaders from hospitals, consultants from venture capital funds and distributors/suppliers of medical equipment and supplies. Historic data and forecasts are relayed to GlobalData s expert panel for feedback and adjusted accordingly. 7.3 GlobalData Consulting We hope that the data and analysis in this brief will help you to make informed and imaginative business decisions. If you have further requirements, GlobalData s consulting team may be able to help you. GlobalData offers tailor-made analytical and advisory services to drive your key strategic decisions. For more information about GlobalData s consulting capabilities 7.5 Disclaimer All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, GlobalData. Page 48